Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry

Fig. 2

PLS-DA scores plot based on the UPLC-MS profiling data for (a) HCC versus HS; (b) HCC versus CH; (c) HCC versus LC; (d) LC versus CH versus HS. Detailed legend: The score plots show the first, second and third latent variables for each plot. Each dot in the plot represents a patient according to its group. HCC, hepatocellular carcinoma; LC, liver cirrhosis; CH, chronic hepatitis; HS, healthy subjects

Back to article page